P
Peter S. Nelson
Researcher at Fred Hutchinson Cancer Research Center
Publications - 497
Citations - 57568
Peter S. Nelson is an academic researcher from Fred Hutchinson Cancer Research Center. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 96, co-authored 425 publications receiving 47923 citations. Previous affiliations of Peter S. Nelson include University of Washington & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Carotid Artery Operation Delay During the COVID-19 Pandemic: Results of A Multi-Center International Study.
Mahmood Kabeil,Max V. Wohlauer,Mario D'Oria,Vipul Khetarpaul,Riley Gillette,Ethan Moore,Kathryn L. Colborn,Robert F. Cuff,Leigh Ann O'Banion,Issam Koleilat,F Azizi,Nicolas J. Mouawad,Amna Ali,L Lucero,Michael J. Costanza,E. Hammond,Raghu L. Motaganahalli,Humraaz Samra,Gregory G. Westin,Kara A. Allen,Ulka Sachdev,Elizabeth Andraska,Melhem J. Sharafuddin,Matthew Carnevale,Paola Batarseh,Britt H. Tonnessen,Nikolai Harroun,A. Šatavičiūtė,Giovanni Tinelli,Jason Chuen,Jonathan Bath,Joseph L. Mills,Rana O. Afifi,Raphaël Coscas,Sherene Shalhub,Adam W. Beck,Fatemeh Malekpour,Michael Cyrus Siah,Mark G. Davies,C. L. Busby,Peter S. Nelson,Sydney Rose Wyatt,Sana Ahmed,Jorge A. Miranda,Inez Ohashi Torres,Albert Abhinay Kota,S. Mier y Teran-Ellis,Gabriella Michelle Lopez,Nalaka Gunawansa +48 more
TL;DR: In this article , a study of patients with carotid artery stenosis who underwent a median delay of 71 days during the COVID-19 pandemic showed a disparate operation delay between US regions and internationally, most postponements were due to hospital policy, and none of the patients deteriorated or required an emergency surgery during the delay.
Journal ArticleDOI
Association of PARP inhibitors and docetaxel resistance through suppressing a tumor microenvironment-associated secretory program.
TL;DR: This data indicates that modulation of the immune response in response to genotoxic stress induced by therapeutics such as radiatio... is a major cause of treatment failures in metastatic cancer.
Journal ArticleDOI
Clinical, pathologic, and molecular features of amphicrine prostate cancer
Laura S. Graham,Michael C. Haffner,Erolcan Sayar,Agnes M. Gawne,Michael T. Schweizer,Colin C. Pritchard,Ilsa L. Coleman,Peter S. Nelson,Evan Y. Yu +8 more
TL;DR: Amphicrine prostate carcinoma (AMPC) is a poorly defined subset of prostate cancer in which cells co-express luminal prostate epithelial and neuroendocrine markers as mentioned in this paper .
Journal ArticleDOI
Internet-Based Germline Genetic Testing for Men With Metastatic Prostate Cancer
Heather H. Cheng,Alexandra O. Sokolova,Roman Gulati,Deborah J. Bowen,Sarah Knerr,Nola M. Klemfuss,Petros Grivas,Andrew C. Hsieh,John Lee,Michael T. Schweizer,Todd Yezefski,Alicia Y. Zhou,Evan Y. Yu,Peter S. Nelson,Bruce Montgomery +14 more
TL;DR: The GentleMEN study as mentioned in this paper was designed to determine the feasibility of an Internet-based, patient-driven approach for men with metastatic prostate cancer (mPC), where men with mPC provided informed consent via an internet-based platform and completed a questionnaire including demographics and family cancer history.
Journal ArticleDOI
The Impact of Work Status and Age in Choosing Type of Abdominal Aortic Aneurysm Repair.
Yiyuan Hu,James M. Jones,C.J. Sensenig,Mark A. Eid,Kunal Mehta,Jenaya L. Goldwag,Jonathan Barnes,Kayla O. Moore,Vivienne J. Halpern,Peter Henke,Gale Tang,Leila Mureebe,Olamide Alabi,Edith Tzeng,David H. Stone,Benjamin S. Brooke,Peter S. Nelson,Emily L. Spangler,M. Barry,Ravinder Kang,Salvatore T. Scali,Jessica O'Connell,Philip P. Goodney +22 more
TL;DR: In this paper , the authors sought to determine the key factors influencing the decision-making of veterans for endovascular repair of abdominal aortic aneurysm (EVAR) or open surgical repair (OSR).